Exact Mass: 476.1430884
Exact Mass Matches: 476.1430884
Found 109 metabolites which its exact mass value is equals to given mass value 476.1430884
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain Temocapril belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Bapta
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside
arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside
5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester
(6R)-7t-[(R)-5-carboxy-5-(3-phenyl-ureido)-pentanoylamino]-3-methyl-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone
(2R,3R)-6-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]pinobanksin 3-acetate
(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside
(10S)-10-C-(4-O-benzoyl-alpha-arabinopyranosyl)-1,8-dihydroxy-3-methylanthracen-9(10H)-one|picramnioside G
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate
C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]
Cys His Met Ser
Cys His Ser Met
Cys Met His Ser
Cys Met Ser His
Cys Ser His Met
Cys Ser Met His
Asp Asp Asn Asn
Asp Asn Asp Asn
Asp Asn Asn Asp
His Cys Met Ser
His Cys Ser Met
His Met Cys Ser
His Met Ser Cys
His Ser Cys Met
His Ser Met Cys
Met Cys His Ser
Met Cys Ser His
Met His Cys Ser
Met His Ser Cys
Met Ser Cys His
Met Ser His Cys
Asn Asp Asp Asn
Asn Asp Asn Asp
Asn Asn Asp Asp
Ser Cys His Met
Ser Cys Met His
Ser His Cys Met
Ser His Met Cys
Ser Met Cys His
Ser Met His Cys
Feclobuzone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
1-[2-Fluoro-3-[[6-methoxy-7-(phenylmethoxy)-4-quinolinyl]oxy]-6-nitrophenyl]-2-propanone
2-Ethoxybenzoic acid [5-methyl-4-(4-methylphenyl)sulfonyl-2-phenyl-3-pyrazolyl] ester
N-(Cyclopropylmethyl)-4-(methyloxy)-3-({5-[3-(3-pyridinyl)phenyl]-1,3-oxazol-2-YL}amino)benzenesulfonamide
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
4-[(3aR,4S,9bS)-8-[(4-methoxyphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]benzoic acid
methyl 5-bromo-3-[[2-(4-cyclohexylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate
Guangsangon L
A member of the class of polyphenols consisting of a methylcyclohexene ring attached to a 2,4-dihydroxyphenyl, 2,4-dihydroxybenzoyl and 2,4-dihydroxybenzaldehyde moieties at positions 5, 4 and 3 respectively. Regarded biogenetically as a Diels-Alder adduct, it is isolated from the stem barks of Morus macroura and exhibits antioxidant activity.
2-(2-Naphthalenylsulfonylamino)acetic acid [2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl] ester
(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(4S,4aR,5R,5aR,6S,11aS,12aR)-4-(dimethylamino)-1,5,6,10,11a,12a-hexahydroxy-6-methyl-3,11,12-trioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
BAPTA
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
5-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
(2r,3s)-2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid
5-[(1s,5r,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
(2R,3 R)-6[1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl]-pinobanksin-3-acetate
{"Ingredient_id": "HBIN006448","Ingredient_name": "(2R,3 R)-6\uff3b1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl\uff3d-pinobanksin-3-acetate","Alias": "NA","Ingredient_formula": "C27H24O8","Ingredient_Smile": "CC(=O)OC1C(OC2=CC(=C(C(=C2C1=O)O)C(C=C)C3=CC(=C(C=C3)O)OC)O)C4=CC=CC=C4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41730","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}